Medicine and Dentistry
Patient with Type 2 Diabetes
100%
Maturity Onset Diabetes of the Young
61%
Semaglutide
44%
Empagliflozin
44%
Cardiovascular Disease
42%
Arterial Stiffness
40%
Pulse Wave Velocity
37%
Type 2 Diabetes
37%
Cohort Analysis
26%
Diabetes
23%
Placebo
23%
Magnetic Resonance Imaging
20%
Endothelial Function
19%
Randomized Clinical Trial
18%
Acetylsalicylic Acid
17%
Physical Activity
17%
Blood Pressure
16%
Coronary Artery Disease
15%
Systolic Blood Pressure
13%
Diabetes Mellitus
13%
Coronary Computed Tomography Angiography
12%
Retinal Blood Vessel
9%
Computed Tomography Angiography
9%
Dual Diagnosis
9%
Antiplatelet
8%
Turner Syndrome
8%
Blood Oxygenation
8%
Fatty Acid Oxidation
8%
Fatty Acid
8%
Non-Alcoholic Fatty Liver Disease
8%
Coronary Risk
8%
Autoregulation
8%
Diffusion MRI
8%
Post-Hoc Analysis
8%
Creatinine
8%
Thrombocyte Aggregation
7%
Medulla
7%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Heart Failure
6%
Apoplexy
5%
Ischemic Heart Disease
5%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
27%
Cardiovascular Disease
25%
Patient with Type 2 Diabetes
24%
Arterial Stiffness
20%
Empagliflozin
17%
Semaglutide
17%
Nuclear Magnetic Resonance Imaging
17%
Pulse Wave
15%
Oxygenation
11%
Placebo
10%
Turnover Rate
8%
Blood Oxygenation
8%
Patient with Diabetes
7%
Cross-Sectional Study
6%
Creatinine
5%
Low Drug Dose
5%
Keyphrases
Proximity Extension Assay
8%
Molecular Detection
8%
Randomized Trial
8%
Calcified Coronary Lesion
8%
Coronary Plaque Burden
8%
Empagliflozin
8%
Total Kidney Volume
8%
Diffusion Magnetic Resonance Imaging (dMRI)
8%
Type 2 Diabetic Patients
8%
Semaglutide
8%
Apparent Diffusion Coefficient
7%
Placebo
6%
Pulse Wave Velocity
5%
